共 24 条
- [1] Dengue and Severe Dengue: Fact Sheet No. 117. In: Dengue and Severe Dengue, (2015)
- [2] Villar L., Dayan G.H., Arredondo-Garcia J.L., Rivera D.M., Cunha R., Deseda C., Et al., Efficacy of a tetravalent dengue vaccine in children in Latin America, N Engl J Med, 372, 2, pp. 113-123, (2015)
- [3] Comprehensive Guidelines for Prevention and Control of Dengue and Dengue Haemorrhagic Fever: Revised and Expanded Edition, (2011)
- [4] Kalayanarooj S., Clinical manifestations and management of Dengue/DHF/DSS, Trop Med Health, 39, 4, pp. 83-87, (2011)
- [5] Lim T.S.H., Grignani R.T., Tambyah P.A., Quek S.C., Impact of dengue-induced thrombocytopenia on mandatory anticoagulation for patients with prosthetic heart valves on warfarin, Singap Med J, 56, 4, pp. 235-236, (2015)
- [6] Srichaikul T., Nimmannitya S., Haematology in dengue and dengue haemorrhagic fever, Bailliere's Best Pract Res Clin Haematol, 13, 2, pp. 261-276, (2000)
- [7] Sellahewa K.H., Pathogenesis of dengue haemorrhagic fever and its impact on case management, ISRN Infect Dis, 2013, (2013)
- [8] Pesaro A.E., D'Amico E., Aranha L.F.C., Dengue: Manifestações cardíacas e implicações na terapêutica antitrombótica, Arq Bras Cardiol, 89, pp. e12-e15, (2007)
- [9] Borosak M., Choo S., Street A., Warfarin: Balancing the benefits and harms, Aust Prescr, 27, 4, pp. 88-92, (2004)
- [10] Patient Information: Warfarin (Coumadin) (Beyond the Basics) [Database on the Internet], (2016)